Interaction of competitive antagonists: the anti-curare action of hexamethonium and other antagonists at the skeletal neuromuscular junction.
1. In the rat isolated diaphragm preparation hexamethonium and other low potency competitive antagonists of acetylcholine (ACh), including gallamine and hyoscine butylbromide, reverse block by the potent antagonists tubocurarine, pancuronium and alcuronium. 2. In the presence of tubocurarine, hexamethonium increases the amplitude of the end-plate potential without increasing the quantal content. It enhances the response to ACh applied iontophoretically to the end-plate but does not enhance the response to ACh applied in the bath. 3. The anti-curare effect of hexamethonium is abolished in the diaphragm of the rat, guinea-pig and mouse by inhibitors of acetylcholinesterase. The effect is not observed in the indirectly stimulated toad sartorius muscle. 4. The effect is explained if tubocurarine does not dissociate appreciably in the time taken for ACh to achieve high occupancy of receptors, so that a fraction of receptors is completely excluded from occupation by ACh. Equilibration with hexamethonium reduces the fraction excluded by tubocurarine and the transmitter now competes with hexamethonium for more receptors and produces a larger response. 5. On the basis of this explanation the half-time for dissociation of tubocurarine must be about 1 millisecond. It follows that tubocurarine does not act competitively with ACh at synapses when transmitter action is sufficiently brief, and that its binding to the receptor is probably diffusion-limited.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000443:Alcuronium / Q000494:pharmacology; D000818:Animals; D001001:Anura; D001667:Binding, Competitive; D008725:Bis-Trimethylammonium Compounds / Q000494:pharmacology; D002714:Chlorisondamine / Q000494:pharmacology; D002800:Cholinesterase Inhibitors; D004347:Drug Interactions; D005703:Gallamine Triethiodide / Q000494:pharmacology; D006168:Guinea Pigs; D006584:Hexamethonium Compounds / Q000494:pharmacology*; D051379:Mice; D009469:Neuromuscular Junction / Q000187:drug effects*; D010197:Pancuronium / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug; D012601:Scopolamine / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects*; D014326:Tropanes / Q000494:pharmacology; D014403:Tubocurarine / Q000037:antagonists & inhibitors* / Q000494:pharmacology
D008725:Bis-Trimethylammonium Compounds; D002800:Cholinesterase Inhibitors; D006584:Hexamethonium Compounds; D011955:Receptors, Drug; D014326:Tropanes; D012601:Scopolamine; D010197:Pancuronium; D002714:Chlorisondamine; D000109:Acetylcholine; D005703:Gallamine Triethiodide; D000443:Alcuronium; D014403:Tubocurarine